GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Croma NV (XAMS:EHCS) » Definitions » Research & Development

Croma NV (XAMS:EHCS) Research & Development : €0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Croma NV Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Croma NV's Research & Development for the six months ended in Dec. 2023 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00 Mil.


Croma NV Research & Development Historical Data

The historical data trend for Croma NV's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Croma NV Research & Development Chart

Croma NV Annual Data
Trend Dec21 Dec22 Dec23
Research & Development
- - -

Croma NV Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Research & Development - - - - -

Croma NV Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Croma NV  (XAMS:EHCS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Croma NV Research & Development Related Terms

Thank you for viewing the detailed overview of Croma NV's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Croma NV (XAMS:EHCS) Business Description

Traded in Other Exchanges
Address
c/o ALR Treuhand GmbH Theresienhohe 28, Munich, BY, DEU, 80338
European Healthcare Acquisition Growth Co BV is a special purpose acquisition company aimed at acquiring companies with principal operations in Europe in the healthcare sector, with a special focus on the subsectors Biotechnology and Specialty Pharma, Pharma Services, Medical Technology and Medical Devices, Diagnostic and Lab Services, Bioinformatics as well as Life Science Tools.

Croma NV (XAMS:EHCS) Headlines

No Headlines